- Home
- CPB vs SNN Comparison
CPB vs SNN Comparison
Compare CPB & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPB
- SNN
- Stock Information
- Founded
- CPB 1869
- SNN 1856
- Country
- CPB United States
- SNN United Kingdom
- Employees
- CPB N/A
- SNN N/A
- Industry
- CPB Packaged Foods
- SNN Industrial Specialties
- Sector
- CPB Consumer Staples
- SNN Health Care
- Exchange
- CPB Nasdaq
- SNN Nasdaq
- Market Cap
- CPB 13.0B
- SNN 11.0B
- IPO Year
- CPB N/A
- SNN 1999
- Fundamental
- Price
- CPB $41.90
- SNN $25.33
- Analyst Decision
- CPB Hold
- SNN Strong Buy
- Analyst Count
- CPB 15
- SNN 1
- Target Price
- CPB $49.93
- SNN N/A
- AVG Volume (30 Days)
- CPB 2.8M
- SNN 646.3K
- Earning Date
- CPB 12-03-2024
- SNN 08-01-2024
- Dividend Yield
- CPB 3.64%
- SNN 2.94%
- EPS Growth
- CPB N/A
- SNN 39.77
- EPS
- CPB 1.83
- SNN 0.35
- Revenue
- CPB $9,890,000,000.00
- SNN $5,642,000,000.00
- Revenue This Year
- CPB $10.56
- SNN $6.97
- Revenue Next Year
- CPB $0.31
- SNN $5.46
- P/E Ratio
- CPB $23.51
- SNN $35.61
- Revenue Growth
- CPB 6.34
- SNN 5.48
- 52 Week Low
- CPB $40.26
- SNN $23.65
- 52 Week High
- CPB $52.81
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- CPB 34.10
- SNN 43.90
- Support Level
- CPB $42.37
- SNN $25.32
- Resistance Level
- CPB $43.38
- SNN $25.70
- Average True Range (ATR)
- CPB 0.78
- SNN 0.29
- MACD
- CPB -0.09
- SNN 0.08
- Stochastic Oscillator
- CPB 10.14
- SNN 19.44
About CPB Campbell Soup Company
Over the past 150-plus years, Campbell has evolved into a leading packaged food manufacturer in North America, with a portfolio that extends beyond its iconic red-and-white labeled canned soup. In fiscal 2024, snacks accounted for nearly half of its revenue, followed by soup (28%), other simple meals (17%), and beverages (7%). Outside its namesake, its brands include Pepperidge Farm, Goldfish, Snyder's of Hanover, Swanson, Pacific Foods, Prego, Pace, V8, and recently acquired Rao's (which closed in March 2024). Around 90% of its revenue results from the US and the remainder from Canada and Latin America.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.